CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Significant Growth in Short Interest

CBD Life Sciences Inc. (OTCMKTS:CBDLGet Rating) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 248,200 shares, an increase of 54.8% from the June 30th total of 160,300 shares. Based on an average daily volume of 102,336,600 shares, the short-interest ratio is presently 0.0 days.

CBD Life Sciences Price Performance

CBD Life Sciences has a 12 month low of $0.00 and a 12 month high of $0.00.

About CBD Life Sciences

(Get Rating)

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Read More

Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.